This topic contains a solution. Click here to go to the answer

Author Question: What is one of the key factors in determining whether a paraphilia is coercive or noncoercive? A) ... (Read 90 times)

P68T

  • Hero Member
  • *****
  • Posts: 509
What is one of the key factors in determining whether a paraphilia is coercive or noncoercive?
 
  A) The number of individuals involved in a specific paraphilia
  B) If the participants need to be talked into engaging in a paraphilia
  C) If the exchange of bodily fluids is involved
  D) If a participant's basic rights are violated in the pursuit of the paraphilia

Question 2

Which of the following would generally NOT be considered a coercive paraphilia?
 
  A) Exhibitionism
  B) Necrophilia
  C) Voyeurism
  D) Fetishism



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

vish98

  • Sr. Member
  • ****
  • Posts: 326
Answer to Question 1

D

Answer to Question 2

D




P68T

  • Member
  • Posts: 509
Reply 2 on: Jun 22, 2018
:D TYSM


recede

  • Member
  • Posts: 315
Reply 3 on: Yesterday
Wow, this really help

 

Did you know?

By definition, when a medication is administered intravenously, its bioavailability is 100%.

Did you know?

Blood is approximately twice as thick as water because of the cells and other components found in it.

Did you know?

Approximately one in three babies in the United States is now delivered by cesarean section. The number of cesarean sections in the United States has risen 46% since 1996.

Did you know?

Walt Disney helped combat malaria by making an animated film in 1943 called The Winged Scourge. This short film starred the seven dwarfs and taught children that mosquitos transmit malaria, which is a very bad disease. It advocated the killing of mosquitos to stop the disease.

Did you know?

Bisphosphonates were first developed in the nineteenth century. They were first investigated for use in disorders of bone metabolism in the 1960s. They are now used clinically for the treatment of osteoporosis, Paget's disease, bone metastasis, multiple myeloma, and other conditions that feature bone fragility.

For a complete list of videos, visit our video library